KLRB1 and neoplasm: In head and neck cancer, CD161 expression was significantly down modulated in the peripheral blood compared to peripheral blood from healthy controls and in tumor infiltrating TH17 cells as a postulated immune escape mechanism induced by the tumor milieu (41).